002737 Stock Overview
Engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. More details
| Snowflake Score | |
|---|---|
| Valuation | 4/6 |
| Future Growth | 0/6 |
| Past Performance | 1/6 |
| Financial Health | 6/6 |
| Dividends | 2/6 |
Sunflower Pharmaceutical Group Co.,Ltd Competitors
Price History & Performance
| Historical stock prices | |
|---|---|
| Current Share Price | CN¥20.03 |
| 52 Week High | CN¥30.79 |
| 52 Week Low | CN¥18.22 |
| Beta | 0.35 |
| 11 Month Change | 0.05% |
| 3 Month Change | -9.98% |
| 1 Year Change | -28.85% |
| 33 Year Change | 35.61% |
| 5 Year Change | 41.86% |
| Change since IPO | 11.77% |
Recent News & Updates
Recent updates
Shareholder Returns
| 002737 | CN Pharmaceuticals | CN Market | |
|---|---|---|---|
| 7D | -1.5% | -1.5% | -2.1% |
| 1Y | -28.8% | -9.4% | 2.8% |
Return vs Industry: 002737 underperformed the CN Pharmaceuticals industry which returned -9.4% over the past year.
Return vs Market: 002737 underperformed the CN Market which returned 2.8% over the past year.
Price Volatility
| 002737 volatility | |
|---|---|
| 002737 Average Weekly Movement | 6.1% |
| Pharmaceuticals Industry Average Movement | 7.3% |
| Market Average Movement | 8.3% |
| 10% most volatile stocks in CN Market | 12.6% |
| 10% least volatile stocks in CN Market | 5.6% |
Stable Share Price: 002737 has not had significant price volatility in the past 3 months compared to the CN market.
Volatility Over Time: 002737's weekly volatility (6%) has been stable over the past year.
About the Company
| Founded | Employees | CEO | Website |
|---|---|---|---|
| 2005 | 5,776 | Yi Guan | www.kuihuayaoye.com |
Sunflower Pharmaceutical Group Co.,Ltd engages in the research and development, manufacturing, and marketing of Chinese patent medicines in China and internationally. The company produces chemical and biological medicines, and health care products. It also provides products covering various therapeutic areas, including pediatrics, gynecology, digestive system, respiratory and cold, rheumatic bone disease, and cardiovascular and cerebrovascular; supplements; and antibiotics and children’s medicinal products.
Sunflower Pharmaceutical Group Co.,Ltd Fundamentals Summary
| 002737 fundamental statistics | |
|---|---|
| Market cap | CN¥11.70b |
| Earnings (TTM) | CN¥854.79m |
| Revenue (TTM) | CN¥4.43b |
13.7x
P/E Ratio2.6x
P/S RatioIs 002737 overvalued?
See Fair Value and valuation analysisEarnings & Revenue
| 002737 income statement (TTM) | |
|---|---|
| Revenue | CN¥4.43b |
| Cost of Revenue | CN¥2.14b |
| Gross Profit | CN¥2.29b |
| Other Expenses | CN¥1.44b |
| Earnings | CN¥854.79m |
Last Reported Earnings
Sep 30, 2024
Next Earnings Date
n/a
| Earnings per share (EPS) | 1.46 |
| Gross Margin | 51.68% |
| Net Profit Margin | 19.29% |
| Debt/Equity Ratio | 0.01% |
How did 002737 perform over the long term?
See historical performance and comparison